StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The firm has a market cap of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- Election Stocks: How Elections Affect the Stock Market
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Stock Splits, Do They Really Impact Investors?
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- Best Aerospace Stocks Investing
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.